Pyrazinecarboxamide compound
US9085540B2 · kind B2 · utility
3Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 2013 |
| Grant date | Jul 21, 2015 |
| Priority date | — |
| Expiry date | Jan 15, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/113
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of formula (I):in which the variables are defined herein, are useful for the treatment of cancer in patients which express the EGFR T790M mutation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.